In-house roundup: Tech convergence set to drive automotive open source acceptance; Section 101 not stopping patenting

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

In-house roundup: Tech convergence set to drive automotive open source acceptance; Section 101 not stopping patenting

open source car thumb

Managing IP rounds up the latest news and analysis from patent-focused businesses

open source car Tech convergence set to drive automotive open source acceptance

Volvo Cars, Lotus and others say car companies are becoming more accepting of suppliers using open source technology as their need for software increases, but that they have to be more vigilant of restrictive licences as a result. Read more... 

EPO: divisional filings a frustration for generic drug companies

In-house counsel from generic drug companies believe pharma innovators are abusing divisional patent filings to give them extra protection. Read more... 

Section 101 uncertainty not stopping patent filing: financial companies

Counsel at Capital One, Wells Fargo and the Clearing House Payments Company say they file patents when there is an appropriate business case and only look at patent eligibility requirements as a secondary issue. Read more... 

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article